Literature DB >> 19617574

Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition.

Michael Rist1, Corey Smith, Melissa J Bell, Scott R Burrows, Rajiv Khanna.   

Abstract

The ability of CD8(+) T cells to engage a diverse range of peptide-major histocompatibility complex (MHC) complexes can also lead to cross-recognition of self and nonself peptide-MHC complexes and thus directly contribute toward allograft rejection or autoimmunity. Here we present a novel form of cross-recognition by herpes virus-specific CD8(+) cytotoxic T cells that challenges the current paradigm of self/non-self recognition. Functional characterization of a human leukocyte antigen (HLA) Cw*0602-restricted cytomegalovirus-specific CD8(+) T-cell response revealed an unusual dual specificity toward a pp65 epitope and the alloantigen HLA DR4. This cross-recognition of HLA DR4 alloantigen was critically dependent on the coexpression of HLA DM and was preferentially directed toward the B-cell lineage. Furthermore, allostimulation of peripheral blood lymphocytes with HLA DRB*0401-expressing cells rapidly expanded CD8(+) T cells, which recognized the pp65 epitope in the context of HLA Cw*0602. T-cell repertoire analysis revealed 2 dominant populations expressing T-cell receptor beta variable (TRBV)4-3 or TRBV13, with cross-reactivity exclusively mediated by the TRBV13(+) clonotypes. More importantly, cross-reactive TRBV13(+) clonotypes displayed markedly lower T-cell receptor binding affinity and a distinct pattern of peptide recognition, presumably mimicking a structure presented on the HLA DR4 allotype. These results illustrate a novel mechanism whereby virus-specific CD8(+) T cells can cross-recognize HLA class II molecules and may contribute toward allograft rejection and/or autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617574     DOI: 10.1182/blood-2009-05-222596

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Programming CMV for vaccine vector design.

Authors:  Srinika Ranasinghe; Bruce D Walker
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908

Review 2.  Recent progress and new perspectives in studying T cell responses to allografts.

Authors:  A Valujskikh; W M Baldwin; R L Fairchild
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

3.  Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.

Authors:  Toshiki Ochi; Munehide Nakatsugawa; Kenji Chamoto; Shinya Tanaka; Yuki Yamashita; Tingxi Guo; Hiroshi Fujiwara; Masaki Yasukawa; Marcus O Butler; Naoto Hirano
Journal:  Cancer Immunol Res       Date:  2015-05-05       Impact factor: 11.151

4.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire.

Authors:  Ryan O Emerson; William S DeWitt; Marissa Vignali; Jenna Gravley; Joyce K Hu; Edward J Osborne; Cindy Desmarais; Mark Klinger; Christopher S Carlson; John A Hansen; Mark Rieder; Harlan S Robins
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

5.  Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.

Authors:  Timothy C Cheung; Ken Coppieters; Hideki Sanjo; Lisa M Oborne; Paula S Norris; Amy Coddington; Steven W Granger; Dirk Elewaut; Carl F Ware
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

Review 6.  Understanding the complexity and malleability of T-cell recognition.

Authors:  John J Miles; James McCluskey; Jamie Rossjohn; Stephanie Gras
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

Review 7.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

8.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

9.  Differential requirements of MHC and of DCs for endogenous proliferation of different T-cell subsets in vivo.

Authors:  Jeong-su Do; Booki Min
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-17       Impact factor: 11.205

10.  Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.

Authors:  Daisuke Ishii; Joshua M Rosenblum; Taiji Nozaki; Austin D Schenk; Kiyoshi Setoguchi; Charles A Su; Victoria Gorbacheva; William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.